Browse all clinical trials articles
EVOKE Phase 3 trials tested semaglutide in early Alzheimer's. The primary endpoint failed. Here is what the data showed and where research goes next.
GLP-1 drugs like semaglutide and tirzepatide show benefits far beyond weight loss — from kidney disease to sleep apnea. What the phase 3 trials show.
Magnesium L-threonate cognitive trial data reviewed: two RCTs show Magtein® improves working memory, reaction time, and sleep quality in adults.
Science-honest summary of NMN and NAD+ human clinical trials through 2026. What the data shows about NAD elevation, walking speed, and metabolic outcomes.
How to evaluate supplement health claims: claim types, third-party certification, red flags, and evidence assessment to make informed choices.
From rapamycin longevity studies to Akkermansia probiotics, these are the 10 supplement clinical trials generating the most compelling data in 2026.
About 54% of supplement benefits in clinical trials may be placebo. Here's what science shows about placebo and nocebo effects in supplement research.
Decentralized clinical trials achieve 97% retention and enroll in weeks. Here's what the evidence shows about their impact on supplement research.
Phase I, II, III, IV — decoded. Learn what each clinical trial phase actually proves and how to spot weak evidence in supplement marketing.
Learn how to read supplement labels with 7 evidence-based steps. Spot adulteration, decode claims, and verify quality using clinical data and third-party testing.
Learn how to read clinical trial results. Understand p-values, effect sizes, red flags, and what supplement study data actually means.
